Vahid Moradi

6 ta ish

Tehran University of Medical Sciences

1. The paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials

   Vahid Moradi, Azadeh Omidkhoda, Naser Ahmadbeigi

   Sharh maqola20239 iqtibos

   ABIABI:AkademIndex/2026.other.475907

2. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

   Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi +2

   Sharh maqola20248 iqtibos

   ABIABI:AkademIndex/2026.other.475925

3. Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors

   Elnaz Khodabandehloo, Mohammad Rayati, Ehsan Ahmadi +3

   Maqola20257 iqtibos

   ABIABI:AkademIndex/2026.other.854910

4. Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy

   Siheng Zhang, Linglong Peng, Yifei Chen +2

   Sharh maqola20244 iqtibos

   ABIABI:AkademIndex/2026.other.475948

5. Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects

   Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman +4

   Sharh maqola20244 iqtibos

   ABIABI:AkademIndex/2026.other.475949

6. Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy

   Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh +2

   Sharh maqola20254 iqtibos

   ABIABI:AkademIndex/2026.other.479139